Senseonics Holdings Inc (SENS)
0.36
-0.01
(-2.04%)
USD |
NYAM |
Sep 20, 16:00
0.37
+0.01
(+2.78%)
After-Hours: 20:00
Senseonics Holdings Research and Development Expense (Quarterly): 10.80M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 10.80M |
March 31, 2024 | 10.44M |
December 31, 2023 | 10.75M |
September 30, 2023 | 12.77M |
June 30, 2023 | 12.83M |
March 31, 2023 | 12.40M |
December 31, 2022 | 11.63M |
September 30, 2022 | 10.98M |
June 30, 2022 | 9.299M |
March 31, 2022 | 7.804M |
December 31, 2021 | 7.655M |
September 30, 2021 | 7.20M |
June 30, 2021 | 7.107M |
March 31, 2021 | 5.255M |
December 31, 2020 | 4.687M |
September 30, 2020 | 4.568M |
June 30, 2020 | 3.796M |
Date | Value |
---|---|
March 31, 2020 | 7.362M |
December 31, 2019 | 9.742M |
September 30, 2019 | 11.08M |
June 30, 2019 | 10.50M |
March 31, 2019 | 7.108M |
December 31, 2018 | 8.058M |
September 30, 2018 | 7.402M |
June 30, 2018 | 8.289M |
March 31, 2018 | 8.113M |
December 31, 2017 | 8.367M |
September 30, 2017 | 9.765M |
June 30, 2017 | 5.604M |
March 31, 2017 | 6.998M |
December 31, 2016 | 5.509M |
September 30, 2016 | 6.883M |
June 30, 2016 | 7.539M |
March 31, 2016 | 6.416M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
3.796M
Minimum
Jun 2020
12.83M
Maximum
Jun 2023
8.908M
Average
9.520M
Median
Research and Development Expense (Quarterly) Benchmarks
Perspective Therapeutics Inc | 9.275M |
Electromed Inc | 0.176M |
Xtant Medical Holdings Inc | 0.636M |
Myomo Inc | 1.007M |
Catheter Precision Inc | 0.081M |